Dr. Eva Haenssler
Associate Director, Product Development, QIAGEN
![Eva Haenssler](/%5E%5Ecdi={B97DE005-4A20-4B74-A750-B6AD53DCC278}%5Ehash=/-/media/project/qiagen/qiagen-home/service-and-support/learning-hub/virtual-events/2024/qrious11/eva-haenssler_sitecore_16x9_1200x675px_nt.jpg)
Eva holds a PhD in Microbiology from the Friedrich-Alexander University Erlangen-Nuremberg. Before joining QIAGEN, Eva worked as a postdoctoral fellow at Tufts University School of Medicine in Boston, MA, USA. Eva is currently an Associate Director at QIAGEN, where her team is responsible for sample technology product development, including solutions for manual and automated extraction from a wide range of sample materials including FFPE tissue samples. Since joining the QIAGEN R&D team in Hilden in 2012, Eva’s work also included sample preparation for microbiome and liquid biopsy applications.
April 24
Dive into a discussion on the significant role of dPCR in the mutational analysis of FFPE tumor samples.
- Digital PCR-based mutation analysis of clinical tumor samples
Prof. Kim Tae-jung, Head of Pathology, The Catholic University of Korea, Yeouido St. Mary’s Hospital, Seoul, South Korea - Panel discussion: Digital PCR applications in cancer research, tips & tricks for FFPE sample preparation and dPCR-based mutational analysis
Prof. Kim Tae-jung and 4 other experts